Cimpuciclib
Cimpuciclib is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].
Product Specifications
CAS Number
2202767-78-8
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cimpuciclib.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCC(CC1)NC2CC2)C3=CC=C(NC4=NC(C5=CC6=C(N=C(C)N6C(C)C)C=C5)=C(F)C=N4)N=C3C
Molecular Formula
C30H35FN8O
Molecular Weight
542.65
References & Citations
[1]Liu Shiqiang, et al. Preparation of benzimidazole compound as kinase inhibitor. Patent WO 2018045956.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; CDK6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
JBD30975-01 50 mg
5,6-Dimethylpiperidine-2-carboxylic acid hydrochloride
Sign In for Pricing
View Details JBD30975-02 0.5 g
5,6-Dimethylpiperidine-2-carboxylic acid hydrochloride
Sign In for Pricing
View Details